Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

Additional Metadata
Persistent URL	doi.org/10.3324/haematol.2017.186601, hdl.handle.net/1765/109741
Journal	Haematologica
Organisation	Department of Hematology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Franssen, L.E. (Laurens E.), Nijhof, I.S. (Inger S.), Couto, S. (Suzana), Levin, M.-D., Bos, G., Broijl, A., Klein, S. K., Ren, Y. (Yan), Wang, M. (Maria), Koene, B., Bloem, A., Beeker, A., Faber, L., van der Spek, E. (Ellen), Raymakers, R., Leguit, P., Sonneveld, P., Zweegman, S., Lokhorst, H., … van de Donk, N. (2018). Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients. Haematologica, 103(8), e368–e371.https://doi.org/10.3324/haematol.2017.186601

Publication